JOURNAL OF CARDIAC FAILURE, cilt.18, sa.5, ss.379-384, 2012 (SCI-Expanded)
Background: Bosentan improves symptoms in patients with Eisenmenger syndrome (ES). This study evaluated the effect of long-term bosentan therapy on cardiac function and its relation to symptomatic benefits in ES patients.